Trafalgar International (GCAN) Revenue Growth (3y) (2020 - 2021)
Trafalgar International (GCAN) Revenue Growth (3y) (2020 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -17.46% |
| Jun 30, 2020 | 769.84% |